Medical management of uterine fibroids with medroxyprogesterone acetate (Depo Provera): A pilot study

Journal of Obstetrics and Gynaecology

Volumn 24, Issue 7, 2004, Pages 798-800

  Venkatachalam, S ^a   Bagratee, J S ^a   Moodley, J ^a  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

MEDROXYPROGESTERONE ACETATE;

AMENORRHEA; ARTICLE; MENORRHAGIA; PILOT STUDY; PREMENOPAUSE; PRIORITY JOURNAL; TREATMENT OUTCOME; TUMOR REGRESSION; TUMOR VOLUME; UTERUS MYOMA;

ADULT; FEMALE; HEMOGLOBINS; HUMANS; LEIOMYOMA; MEDROXYPROGESTERONE 17-ACETATE; MENORRHAGIA; PILOT PROJECTS; PREMENOPAUSE; TREATMENT OUTCOME; UTERINE NEOPLASMS;

EID: 10444228015     PISSN: 01443615     EISSN: None     Source Type: Journal    
DOI: 10.1080/01443610400009543     Document Type: Article

References (12)

1. Benagiano G., Morini A., Aleandri, V., Piccinno F., Primiero F. M., Abbondante G. and Elkind-Hirsch K. (1990) Sequential Gn-RH superagonist and medroxyprogesterone acetate treatment of uterine leiomyomata. International Journal of Gynaecology and Obstetrics, 33, 333-343.
2. Buttram V. C. and Reiter R. C. (1981) Uterine leiomyomata. Fertility and Sterility, 36, 433-445.
3. Carlson K. J., Miller B. A. and Fowler F. J. Jr (1994) The Maine Women's Health Study: II. Outcomes of nonsurgical management of leiomyomas, abnormal bleeding, and chronic pelvic pain. Obstetrics and Gynaecology, 83, 566-572.
4. Cramer D. W. (1992) Epidemiology of myomas. Seminars in Reproductive Endocrinology, 10, 320-324.
5. Davis K. M. and Schlaff W. D. (1995) Medical management of uterine fibromyomata. Obstetrics and Gynecology Clinics of North America, 22, 727-738.
6. Fraser I. S., McCarron, G., Markham R., Resta T. and Watts A. (1986) Measured menstrual loss in women with menorrhagia. Obstetrics and Gynecology, 68, 630-633.
7. Friedman A. J., Harrison-Atlas D., Barbieri R. L., Benacerraf B., Gleason R. and Schiff I. (1989) A randomized, placebo-controlled, double-blind study evaluating the efficacy of leuprolide acetate depot in the treatment of uterine leiomyomata. Fertility and Sterility, 51, 251-256.
8. Healy D. L., Lawson S. R., Abbott M., Baird D. T. and Fraser H. M. (1986) Toward removing uterine fibroids without surgery: subcutaneous infusion of a luteinizing hormone-releasing hormone agonist commencing in the luteal phase. Journal of Clinical Endocrinology and Metabolism, 63, 619-625.
9. Kjerulff K. H., Langenberg P., Seidman J. D., Stolley P. D. and Guzinski G. M. (1996) Uterine leiomyomas. Racial differences in severity, symptoms and age at diagnosis. Journal of Reproductive Medicine, 41, 483-490.
10. Lumbiganon P., Rugpao S., Phandhu-fung S., Laopaiboon M., Vudhikamraska N. and Werawatakul Y. (1996) Protective effect of depot-medroxyprogesterone acetate on surgically treated uterine leiomyomas: a multicentre case-control study. British Journal of Obstetrics and Gynaecology, 103, 909-914.
11. Reiter R. C. (1994) Uterine leiomyomata. ACOG Technical Bulletin, pp. 192.
12. Vikhlyaeva E. M., Khodzhaeva Z. S., Fantschenko N. D. (1995) Familial predisposition to uterine leiomyomas. International Journal of Gynaecology and Obstetrics, 51, 127-131.